Formulary Search Results for: SODIUM ZIRCONIUM CYCLOSILICATE emergency
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
Prescribing Notes:
Risedronate is the second line bisphosphonate for osteoporosis and should only be used in patients who either fail to tolerate alendronic acid because of gastrointestinal side effects or when alendronic acid is considered inappropriate because of existing active dyspeptic symptoms. Treatment of osteoporosis in men at high risk of fractures remains non-Formulary.
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
7.4.3 Drugs used in urological pain - View Category
Restrictions:
Restricted to specialist initiation for the treatment of bladder pain syndrome characterised by either glomerulations or Hunner's lesions in adults with moderate to severe pain, urgency and frequency of micturition where other treatment options have failed, are not tolerated or are not appropriate.
2.5.1 Vasodilator antihypertensive drugs - View Category
2.8.1 Parenteral anticoagulants - View Category
2.13 Local sclerosants - View Category
9.8.1 Drugs used in metabolic disorders - View Category
Restrictions:
This is an orphan product and restricted to specialist initiation.
Prescribing Notes:
Available granule formulations are not dose equivalent and are not interchangeable and should be prescribed by brand name to avoid confusion.
16.2 Specific antidotes - View Category
8.4 Drugs for cytotoxic-induced side effects - View Category
Restrictions:
Restricted to specialist use only for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours.